FDA Compliance for Nutraceutical Companies
Navigate DSHEA regulations, cGMP requirements, NDI notifications, and labeling rules. From facility registration to adverse event reporting, we cover everything nutraceutical companies need to know about FDA compliance.
Trusted by 2,800+ companies in 160+ countries
Understanding Nutraceutical Regulations
Nutraceutical products in the United States are primarily regulated as dietary supplements under the Dietary Supplement Health and Education Act of 1994 (DSHEA). While the term "nutraceutical" is widely used in the industry, it is not a legally defined term by FDA. Products marketed as nutraceuticals must comply with the same regulatory requirements as dietary supplements.
The nutraceutical industry faces increasing FDA scrutiny, particularly around new dietary ingredients, manufacturing quality, and marketing claims. Companies that proactively build strong compliance programs are better positioned to avoid enforcement actions and build consumer trust in an increasingly competitive market.
Key areas of regulatory focus include cGMP compliance under 21 CFR Part 111, New Dietary Ingredient (NDI) notification requirements, proper labeling with Supplement Facts panels, adverse event reporting, and the critical distinction between permissible structure/function claims and prohibited disease claims.
Key Regulatory Framework
Quick Links
Need Help?
Our experts can guide you through nutraceutical compliance.
Requirements Checklist
Nutraceutical companies must meet these fundamental regulatory requirements to legally market products in the United States.
FDA Facility Registration
All nutraceutical manufacturing, processing, packing, and holding facilities must register with FDA
Product Listing
All dietary supplement products must be listed with FDA including ingredients, labeling, and responsible person
NDI Notification
75-day premarket notification required for any New Dietary Ingredient not marketed before October 15, 1994
cGMP Compliance
21 CFR Part 111 requires identity testing, batch records, quality controls, and CAPA procedures
Supplement Facts Labeling
Proper Supplement Facts panel, ingredient list, allergen declarations, and required disclaimers
Adverse Event Reporting
Serious adverse events must be reported to FDA within 15 business days; maintain records for 6 years
DSHEA: The Foundation of Supplement Regulation
The Dietary Supplement Health and Education Act of 1994 (DSHEA) is the primary federal law governing dietary supplements. It defines what a dietary supplement is, establishes labeling rules, and sets the framework for claims manufacturers can make.
What DSHEA Defines as a Dietary Supplement
Under DSHEA, a dietary supplement is a product (other than tobacco) that:
Key DSHEA Provisions
Unlike drugs, dietary supplements do not require FDA approval before they can be marketed. However, the manufacturer is responsible for ensuring safety and accurate labeling.
DSHEA places the burden on FDA to prove that a supplement is unsafe or misbranded before it can take enforcement action, rather than requiring manufacturers to prove safety pre-market.
DSHEA permits manufacturers to make claims about how a nutrient affects the structure or function of the body (e.g., 'supports joint health'), provided a disclaimer is included and FDA is notified within 30 days.
DSHEA mandated the creation of the Supplement Facts panel (distinct from Nutrition Facts for conventional foods) to provide consumers with standardized ingredient and dosage information.
Dietary ingredients marketed in the US before October 15, 1994, are considered grandfathered and do not require NDI notification. However, manufacturers must still ensure these ingredients are safe under conditions of use.
New Dietary Ingredient (NDI) Notifications
Under 21 CFR Part 190.6, manufacturers must submit a premarket notification to FDA at least 75 days before marketing any dietary supplement containing a New Dietary Ingredient (NDI).
What Qualifies as an NDI?
A New Dietary Ingredient is a dietary ingredient that was not marketed in the United States in or as a dietary supplement before October 15, 1994. The determination of whether an ingredient is an NDI depends on:
Chemical Alteration Rule
If a dietary ingredient has been "chemically altered" from the form marketed before October 15, 1994, it is considered a New Dietary Ingredient requiring notification. This includes synthetic versions of naturally occurring ingredients, novel extraction methods that substantially change the ingredient's chemical composition, and nano-formulated versions of traditional ingredients.
NDI Notification Requirements (21 CFR 190.6)
The NDI notification must be filed at least 75 days before the product enters commerce and must include:
Name, chemical/molecular composition, botanical source (if applicable), and specifications
Intended daily dose, duration of use, target population, and any warnings or contraindications
Documentation of prior use in food or supplements, including international use data where available
Basis for the conclusion that the NDI will reasonably be expected to be safe, including toxicology studies, clinical trials, and published literature
Description of manufacturing process, quality controls, stability data, and specifications for the NDI
FDA Review: FDA reviews NDI notifications during the 75-day period and may issue an objection letter if the safety evidence is insufficient. Historically, FDA has objected to a significant percentage of NDI notifications. Products marketed without a required NDI notification are considered adulterated under section 402(f) of the FD&C Act.
cGMP Compliance (21 CFR Part 111)
The dietary supplement cGMP rule establishes comprehensive requirements for manufacturing, packaging, labeling, and holding operations. Compliance is mandatory for all nutraceutical manufacturers regardless of company size.
These regulations ensure that nutraceutical products are produced in a quality manner, do not contain contaminants or impurities, and are accurately labeled. FDA conducts regular inspections to verify compliance.
Key cGMP Elements
21 CFR Part 111: cGMP Subpart Breakdown
The dietary supplement cGMP regulation contains multiple subparts, each covering a distinct area of manufacturing operations. Understanding each subpart is essential for building a comprehensive compliance program.
Personnel
Physical Plant & Grounds
Equipment & Utensils
Requirement to Establish a Production & Process Control System
Production & Process Controls
Records
FDA Inspection Focus Areas
During cGMP inspections, FDA investigators most frequently cite violations in identity testing (Subpart F), batch records (Subpart L), product specifications (Subpart E), and CAPA procedures. Companies with robust documentation systems and consistent testing programs are significantly less likely to receive FDA Form 483 observations during inspection.
Structure/Function Claims
DSHEA allows manufacturers to make claims about how a nutrient or dietary ingredient affects the structure or function of the body. Understanding the rules around these claims is critical to avoiding FDA enforcement action.
Permissible Claims
Structure/function claims describe how a nutrient or dietary ingredient affects the normal structure or function of the human body. Examples of permissible claims include:
Requirements for Making Claims
Manufacturers must have adequate evidence (competent and reliable scientific evidence) to support each claim before making it
Manufacturers must notify FDA within 30 days of first marketing a product with a structure/function claim
The label must include: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."
All claims must be truthful, not misleading, and supported by the totality of publicly available scientific evidence
Prohibited Disease Claims
The following types of claims are prohibited for dietary supplements and will render the product an unapproved new drug:
Types of Permitted Health Claims
FDA-approved claims supported by significant scientific agreement (SSA). Example: 'Calcium and Vitamin D may reduce the risk of osteoporosis.'
Claims supported by some, but not conclusive, scientific evidence. Must include qualifying language specified by FDA. Subject to petition process.
Claims about how a nutrient affects body structure or function. Most commonly used by supplement companies. Require disclaimer and 30-day FDA notification.
Supplement Facts Panel Requirements
The Supplement Facts panel is a distinct labeling format required for all dietary supplements, as opposed to the Nutrition Facts panel used for conventional foods. Getting it right is essential for FDA compliance.
Supplement Facts vs. Nutrition Facts
| Element | Supplement Facts | Nutrition Facts |
|---|---|---|
| Used for | Dietary supplements | Conventional foods |
| Serving size | Per dosage unit (tablet, capsule, scoop) | Per household measure |
| % Daily Value | Where established; dagger for no DV | Required for all listed nutrients |
| Ingredient listing | Dietary ingredients + other ingredients | All ingredients in descending order |
| Proprietary blends | Allowed with total blend weight | Not applicable |
Panel Contents (Required Elements)
Proprietary Blend Rules
Proprietary blends may list total weight of the blend without disclosing individual ingredient amounts. However, all ingredients in the blend must be listed in descending order of predominance by weight. The total weight of the proprietary blend must be declared. FDA has increased scrutiny of proprietary blends and is considering rule changes to require individual ingredient amounts.
Labeling Requirements
Nutraceutical labels must include specific information in the format and location required by FDA regulations.
Label Requirements
Required Disclaimer
If making structure/function claims, you must include:
Prohibited Claims
Nutraceutical products cannot make disease claims such as "treats diabetes," "cures cancer," or "prevents heart disease." Such claims render the product an unapproved drug subject to FDA enforcement action including seizure and injunction.
NDI Requirement
Any ingredient not marketed as a dietary supplement before October 15, 1994, requires a 75-day premarket notification to FDA with safety evidence before it can be used in a product.
Common Compliance Failures
Learn from the most frequently cited violations in FDA warning letters and enforcement actions against nutraceutical companies.
Unapproved Disease Claims
Marketing products with claims to treat, cure, or prevent diseases such as cancer, diabetes, or heart disease
Products deemed unapproved drugs, warning letter, seizure, injunction
Limit to structure/function claims with proper disclaimer; have regulatory expert review all marketing materials
Undeclared Ingredients
Products containing undeclared drug ingredients, allergens, or ingredients not listed on the label
Mandatory recall, warning letter, criminal prosecution
Implement 100% identity testing of incoming ingredients; verify supplier CoAs independently
cGMP Violations
Failure to follow manufacturing controls including lack of identity testing, inadequate batch records, or poor facility conditions
Form FDA 483, warning letter, import alert, product seizure
Conduct internal audits, maintain comprehensive records, train all personnel on cGMP requirements
No NDI Notification
Marketing products containing New Dietary Ingredients without the required 75-day premarket notification to FDA
Products deemed adulterated, enforcement action, market withdrawal
Evaluate all ingredients for NDI status; submit notification with safety evidence at least 75 days before marketing
Inadequate Adverse Event Reporting
Failing to report serious adverse events within 15 business days or not maintaining required records
Warning letter, potential criminal liability, loss of consumer trust
Establish formal AE reporting system with trained personnel; maintain records for 6 years
Nutraceutical Compliance Pricing
Transparent pricing for nutraceutical compliance services. No hidden fees.
Food Facility Registration
Facility registration for nutraceutical manufacturing sites
- FDA facility registration
- UFI number assignment
- Biennial renewal reminders
- Registration confirmation certificate
US Agent
US Agent designation for foreign manufacturers
- FDA-compliant US Agent
- 24/7 emergency availability
- FDA communication handling
- Annual registration renewals
Cosmetics/MoCRA
For nutraceutical-cosmetic crossover products
- MoCRA facility registration
- Product listing
- Adverse event reporting support
- Responsible person designation
Frequently Asked Questions
Get answers to the most common questions about nutraceutical FDA compliance.
What is the difference between a nutraceutical and a dietary supplement?
In the United States, 'nutraceutical' is not a legally defined term by FDA. Products commonly called nutraceuticals are generally regulated as dietary supplements under DSHEA. A dietary supplement is a product taken by mouth that contains a dietary ingredient (vitamins, minerals, herbs, amino acids, etc.) intended to supplement the diet. Regardless of the marketing term used, if a product meets the definition of a dietary supplement, it must comply with DSHEA and all applicable FDA regulations.
Do nutraceutical products require FDA approval before sale?
No, dietary supplements (including nutraceuticals) do not require FDA pre-market approval. However, manufacturers must: (1) Register their facility with FDA, (2) Ensure products are safe and properly labeled, (3) Comply with cGMP regulations (21 CFR Part 111), (4) Submit NDI notifications for any new dietary ingredients, and (5) Not make drug claims. FDA can take enforcement action against unsafe, mislabeled, or illegally marketed products at any time.
What is a New Dietary Ingredient (NDI) and when do I need to file?
A New Dietary Ingredient (NDI) is a dietary ingredient that was not marketed in the United States in or as a dietary supplement before October 15, 1994. If your product contains an NDI, you must submit a notification to FDA at least 75 days before marketing, providing evidence of reasonable expectation of safety. This includes safety data from studies, published literature, and history of use. FDA reviews the notification and may object if the evidence is insufficient.
What are the cGMP requirements for nutraceutical manufacturers?
The dietary supplement cGMP rule (21 CFR Part 111) requires manufacturers to: conduct 100% identity testing of incoming dietary ingredients, establish product specifications, maintain master manufacturing and batch production records, implement quality control procedures, follow written CAPA procedures, train all personnel, calibrate equipment, and maintain facility cleanliness. All manufacturers must comply regardless of company size.
Can I make health claims on my nutraceutical product?
There are three types of claims: (1) Authorized Health Claims - FDA-approved claims linking a substance to a disease or health condition, (2) Qualified Health Claims - supported by some evidence but require qualifying language, (3) Structure/Function Claims - describe how a nutrient affects body structure or function (e.g., 'supports immune health'). Structure/function claims require the FDA disclaimer and 30-day notification. Disease claims ('treats diabetes') are never allowed without drug approval.
Do foreign nutraceutical manufacturers need a US Agent?
Yes, all foreign facilities that manufacture, process, pack, or hold dietary supplements for US export must designate a US Agent. The US Agent must reside in the US or maintain a place of business in the US, acts as a communication liaison between FDA and the foreign facility, and must be available 24/7 for emergencies. Assurentry provides US Agent services for foreign nutraceutical manufacturers at $399/year.
Our Nutraceutical Compliance Services
Let our experts handle your compliance needs so you can focus on growing your nutraceutical business.
Related Resources
Dietary Supplement Labeling Guide
Complete guide to supplement labeling requirements including Supplement Facts panels and claims.
Dietary Supplements Industry Page
In-depth FDA compliance guide specifically for dietary supplement companies.
Ingredient Safety Checker
AI-powered ingredient risk assessment for nutraceutical products.
FDA Warning Letters Search
Search and analyze FDA warning letters issued to nutraceutical and supplement companies.
Ready to Ensure Your Nutraceutical Compliance?
Get personalized guidance from our FDA compliance experts. We'll help you navigate DSHEA, cGMP, NDI notifications, and labeling requirements.